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Abstract
The question of how to compare survival between two 
or more groups is considered mainly with a view to 
applications in medical studies* Emphasis is laid on 
finding methods of comparison which are simple to perform, 
and on the presentation of the results in a form which 
may readily be understood by the layman.
The main nonparametric methods of estimating a 
survival distribution are described, and the connections 
between them pointed out. Parametric methods considered 
are those based on the exponential and Weibull 
distributions. The comparison of two groups is considered 
in detail, particular attention being paid to simple 
graphical methods, and to the clarification of some points 
arising from the recent papers by Gox (1972) and Pete and 
Peto (1972).
Where account is to be taken of concomitant 
variables, the important regression models available are 
those based on the exponential distribution and Cox's 
model, in which the form of the underlying distribution 
remains arbitrary. These are presented as extensions of 
the two-sample models already considered. Where there 
are many possible covariates, computation becomes heavy 
and there is a danger that the results may be difficult to 
interpret. It is suggested that a preliminary analysis of 
the data in strata by simple two-sample methods be made, 
as an aid in deciding which covariates to include in the 
model; a subsequent regression analysis might then be 
presented as a refinement of this. Such a preliminary
analysis is demonstrated on a body of data from a 
clinical trial.
10. Introduction
A number of subjects are observed from the 
occurrence of some initiating event until failure occurs, 
and their failure times noted. The subjects might be 
patients after a heart attack, observed from the time of 
the attack until death, leukaemia patients observed from 
the beginning of remission until the re—appearance of 
symptoms, or experimental animals treated with a 
carcinogen and observed from the start of treatment until 
the appearance of a tumour. The time until failure is 
referred to as survival time.
Suppose the subjects may be divided into two or more 
groups according to some factor which may affect survival. 
The heart patients, for example, might be given different 
treatments, the leukaemia patients might be classified as 
having high or low white blood cell count at diagnosis, 
and the experimental animals might be treated with two or 
more different doses of the carcinogen. The object is to 
estimate the survival distribution for each group and 
make a comparison.
If numbers are fairly large, it is a simple matter 
to estimate and draw survival curves (see f 1.1) for the 
various groups and compare these visually. Where numbers 
are smaller the analysis is complicated in two ways. The 
first is that the distribution of failure times is usual­
ly far from normal, being considerably skew to the right. 
This makes conventional methods of analysis difficult to 
^PPly> particularly as any difference in shapes between 
groups is of great importance. The second is the problem
of competing risks. It is seldom that all subjects can 
be observed until failure. Some of the patients in a 
clinical trial may withdraw from the trial, or may be 
still alive or in remission at the end of the trial. 
Experimental animals may die without developing a tumour. 
If this happens, we know only that the survival time is 
greater than some value, called the censoring time. The 
observation is referred to as right-censored or simply 
censored.
It is because of these two complications that a 
number of special techniques have been evolved for dealing 
with what is otherwise a standard problem in statistics: 
the estimation and comparison of two or more 
distributions.
31. Estimating a Survival Distribution
1.1 Theory and notation
Let T  be a random variable representing survival 
time for an individual, and let F(t) be the cumulative 
distribution function of survival times: F(t) = K‘{T ^  ^  •
The survivor function is defined as J
that is, the probability that the individual survives at 
least time t , The graph of J(t) is called the survival 
curve.
F(^ t)= - y (k ) , the probability density
function of survival time.
Because an individual can only fail once, it is 
convenient to work with the p.d.f. of survival time 
conditional on failure not having already occurred. This 
is the age-specific failure rate or hazard A(t), In most 
medical applications it is sensible to assume that the 
hazard is a continuous or piecewise continuous function 
of time. Then
\(;t)= . J(b)
' 3 ( t )  - 5(t)
, M t ) =  -  ^  {en?(t)j (1*2)
. . 3 (t)- exj^ J" A(3i) d-ji J = eXf>[^ -H(Uj (1'3)
where H(t) is the cumulative hazard function.
These relations show that the distribution is 
uniquely determined by any of the five functions F(t), 
t), X[fcj, H(tj. Note that, from ( 1. %), — \(t)
4represents the gradient of the log survival curve (the 
graph of 3 (t) = - H(t)).
If X[t) is a discrete function of time, failure is 
only permitted at times for which there is a non-zero 
hazard. Although not realistic for medical studies, this 
model is useful for theory when dealing with nonparametric 
methods. Then the conditional probability
that an individual fails at time , given that he has 
not already failed. Since it is no longer true that 
j^ (b) - - 3 (k), equations (1.2) and (1.3) no longer hold. 
The cumulative hazard function is now defined by
H  (fc) = X  (t J  . (1.4)
In estimating the survival distribution for a sample, 
we assume that the failure times for individuals are 
independently and identically distributed. It is 
necessary to distinguish between two types of data, 
grouped and exact. With grouped data the total 
observation period is divided into time intervals [To,I^|)» 
[t , ^ T;^ ),... jTf^), where To=0. In the Lth interval 
[ip,, %(^ ) there are subjects at risk at the beginning of
the interval, and failures and t i  censorings during
the interval. Then Provided that the
intervals are fairly short, little information will be 
lost by assuming that censorings occur at the ends of the 
intervals, after the failures; in order to simplify the 
notation, this assumption will be made throughout.
If observation is continuous, so that exact times of
5failure or censoring are known, we may write these in 
order of occurrence as
L| , c, , ^2 , c%, . . .
where an asterisk denotes a censored observation. For 
truly continuous observation only one failure or censor­
ing may occur at any given time; however, we extend this 
case to include slight grouping so that failures may 
be recorded at time ti^, which is still taken to be exact. 
Just before time k[ there are Y'l subjects at risk. If a 
failure and a censoring are both recorded at it will 
be assumed that the failure occurs first.
1.2 Some nonparametric methods of estimation 
An actuarial method
Actuarial methods are used where numbers are fairly 
large, and involve some assumption about the form of the 
hazard. If we assume that the hazard is a constant \ l  
over the Cth interval, so that the survival curve is a 
series of connected straight lines, a reasonable estimate 
for \ i  is the mid-interval failure rate given by
 —  • (1.5)
Using (1.3), the survivor function is estimated by
A  ^  A  A
= T T e ’ *■ =
t-iA
and ) may be found for t in any interval by inter­
polation.
bPig.1 Log survival curve 
actuarial estimate
She life-table method
This method is also used for grouped data. V/ithout 
making any assumption about the hazard, the probability 
of failing in the lth interval is estimated by
K  “ re
and if these are regarded as independent probability 
estimates the survivor function at T,, 1^,... is 
estimated by aiCci) = I 0-k)
A -^ "1
3 (,b) is undefined elsewhere, but values may be inter­
polated by imposing some assumption about the hazard.
0
-c.
Pig.2 Log survival curve: 
life-table estimate.
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If the hazard is assumed constant over the interval 
its value is estimated from (1.3) by
( T i - T i - i ) h  (1 -  (1 .6 )
Note that this is the same as (1.5), to the second order 
in Üîi o
The product-limit method
V/here the sample is small and exact times of failure 
known, the observation intervals may be made arbitrarily 
small so that each includes at most one failure. Then 
the probability of surviving the lth interval is 
estimated by
 ^' f,"r j — if the interval contains a failure
1 I otherwise.
Clearly, intervals in which no failure occurs produce no 
change in the estimated survivor function. Then if the t i  
are the recorded failure-times,
5(t) --II (l - f j  , (1.7)
t
and if there is slight grouping so that failures are 
recorded at t[,
l(k) = I T  (l - 7--) . (1.8)
k-b
Kaplan and Meier (1958) showed that the product-limit 
(PL) estimate given by (1.7) or (1.8) is the maximum
8likelihood (ML) estimate in the family of all possible 
distributions. It is a step-function corresponding to a 
discrete hazard with values estimated by
r
re 
\ 0
t ^e ) ...
elsewhere
(1.9)
so that
H(b) - Z
bi < i
Mi
r i
(1.10)
gives the ML estimate of the cumulative hazard.
A  A
Note that, from (1.8) and (1.10), in 5(t) —  H(b),
to the first order in , so that the relation of (1.3) 
holds approximately between the estimates.
If there is no censoring, successive terms of the
A
product cancel out, and 3‘(t)= proportion surviving at 
time t. 3(6 ) is zero after the last observation if this 
is a failure, but indeterminate if it is a censoring.
Fig.3 Log survival curve 
PL estimate.
Because the discrete-hazard model is unrealistic for 
medical studies, it is natural to impose some smoothing
on the hazard. This would not necessarily lead to the
A A
same ML estimate for However, the values of 3
A
and H(tJ from (1.8) and (1.10) may be regarded as point- 
estimates for a model in which the hazard is assumed 
continuous. Smoothing is then achieved by taking the 
hazard as constant between failure-times. One such 
method, used by Breslow, is described in  ^2.4.
1.3 Parametric methods of estimation
Distributions specifically proposed for survival 
problems include the exponential, Weibull and Gompertz. 
The two former, in particular, often provide a good fit 
when the failure rate is high, as happens, for example, 
in clinical trials designed to compare mortality from 
cancer or heart disease.
The exponential distribution
Suppose the hazard is constant, so that A(t)- ^ for 
all t. Then jf(t)= ^ { t ) = and the expected
value of survival time = £(t) = "X •
Let N subjects be observed to failure or censoring, 
and n of these fail. The contribution to the likelihood 
from a failure at time b|^ is - A and that from
a censoring at time is The log-
likelihood is
L - “ A ZL t • t n A - X t
J L
and the ML estimate of A is given by
,-A t
f
10
A _ ______n  _ number of deaths /n  ^ \
^ " total of observation times
j ' i '
The Weibull distribution
A common form of departure from the exponential 
model is that where V / 1. Then
X(b) = that is, the hazard is monotonie
increasing if v>l, and monotonie decreasing if I •
With the notation of 1.1, jT;:'
-r- V
so that 1 is exponentially distributed with parameter 
. Hence if v is known, the methods outlined for the 
exponential distribution may be used to find X . If V is 
not known, iterative methods are required for the solution 
of the ML equations for X and .
Modified exponential and Weibull distributions
For certain animal tumour experiments and obser­
vations on times in remission for leukaemia patients, 
Zelen (1966) suggests the model with survivor function
3 ( b)  = ( t > q )
in which there is a time-lag before the downward 
exponential trend begins. Joint ML estimation of A and 
is straightforward.
A model which provides a good fit in many 
carcinogenesis experiments has
g  ( b )  = £ - V ( t - u r ) '  ( b > u r ) .
11
Once u3 and k are known, the ML estimate of A may readily 
be obtained. However, joint estimation of uT and k is 
difficult as the distribution is almost degenerate (Peto 
and Lee, 1973). It is often possible to fix one of these 
parameters according to its physical meaning.
1.4 Summary
Some terms used in the analysis of survival data are 
defined. Nonparametric methods of estimating the 
survivor function from the data are considered, the chief 
of these being the product-limit method. Parametric 
methods based on maximum likelihood are outlined for the 
exponential and Weibull distributions.
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2. The Two-sample Case
Vbry often, survival experience is to be compared 
for just two groups; some typical examples are given in 
 ^0. For this section we assume that any additional 
factors, such as age, which might affect survival are 
similarly distributed over the two groups.
2.1 Parametric methods of comparison 
Underlying exponential distribution
If we may assume that the hazards for the two groups 
are constants A,, respectively, the method of 
comparison is particularly straightforward. Let J, , %  be 
the totals of observation times, and n,, the numbers 
of failures for the two groups. Then, using (1.11), the 
ratio of the hazards is estimated by
3, %
X  " X n ,  ■
It can be shown that 2 is distributed as with
d cl
2.1b degrees of freedom (j = 1,2), so that
l a .  -  V  F , ,  , >
A, " ’
yielding a test of the null hypothesis 1, and 
confidence limits for the ratio of hazards.
Illustration: Table 1 shows a set of data of Freireich
et al quoted by Cox (1972), on times of remission of 
two groups of leukaemia patients.
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Table 1. Times of remission of leukaemia patients (weeks)
Group 1 (drug 6-MP): 6*,6,6,6,7,9*,10*,10,11*,13,16,17*,
191^^^^22,23,25*,32*,32*,34*,35*
Group 2 (control): 1,1,2,2,3,4,4,5,5,8,8,8,8,11,11,12,
12,15,17,22,23
(^  denotes censored observation)
], =35 9, n, = 9 = 35-9x11 = , ^
3%= 182, A| 18,2 X 9
Upper and lower 2^^ points of F(/j.2,jg) are 2,19, 0.471 
respectively
95^ confidence interval for is ( lA.7 k359xZI ^ 2-19>*<35^ x2 A
 ^ I8%x9 /
= ( Ï - S  , II 3)
Underlying Weibull distribution
If a common index \) is assumed for the two curves, 
the survivor functions may be written as
3-, ( t )  = exf> , % (b) = ex<p [-( \i.b )7  ,
giving the constant ratio of hazards as ^ . If v = 1, 
the Weibull distribution reduces to the exponential.
For the data of Table 1, Gox (1972) gives the ML 
estimate of the index as v = 1.3, and finds that this is 
just significantly different from 1 at the level.
Cox's ML estimate of is 3»7, which leads to the
estimate ( =  5.6 for the ratio of hazards.
xj
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Hazard plotting
This gives a quick graphical method of comparing two 
sets of survival data for which the form of the under­
lying distribution may be assumed.
Suppose first that the hazards are constant (expo­
nential distribution). Then the cumulative hazards for 
the two groups are given by
ÆHj(t) -- = Ajt =
The graph of against t is a straight line through
the origin, whose slope is Xj. For each group separate­
ly, point estimates of cumulative hazard at the times of 
failure are found using (1.10). The two cumulative 
hazards are plotted on the same graph, straight lines 
fitted by eye, and an estimate of the ratio of hazards 
obtained. A systematic departure from a straight line 
would lead to questioning of the assumption of constant 
hazard. However, in fitting a straight line it must be
A
bourne in mind that the estimate H(t;) becomes 
increasingly unreliable as the risk set dwindles, so less 
importance should be attached to plotted points further 
from the origin. This is especially so when the data are 
few.
If the Weibull distribution with connnon index is 
assumed, 5j(b) - (j = 1,2).
Irom (1.3) = (\j
(2.1)
A
A plot of log Hj (t ) against t. (or (t) against
15
t on double logarithmic paper) gives a pair of parallel 
straight lines, with slope v and intercepts logX, , u logA^ .^
Nelson (1972) works out appropriate scales for the 
axes for a number of alternative distributions. Special 
hazard plotting papers are available which have suitable 
non-linear scales on one or both axes, such as the double 
logarithmic paper mentioned for the Weibull distribution. 
Nelson also points out that hazard plotting is equivalent 
to probability plotting for the corresponding cumulative 
distribution function.
A
Table 2. Calculation of H (t) for the data of Table 1.
Group 1:
Group 2:
bi M i fi /rc
6 3 21 0.1429 0.14
7 1 17 0.0588 0.20
10 1 15 0.0667 0.27
13 1 12 0.0833 0.35
16 1 11 0.0909 0.44
22 1 7 0.1429 0.59
23 1 6 0.1667 0.75
1 2 21 0.0952 0.10
2 2 19 0.1053 0.20
3 1 17 0.0588 0.26
4 2 16 0.1250 0.38
5 2 14 0.1429 0.53
8 4 12 0.3333 0.86
11 2 8 0.2500 1.11
12 2 6 0.3333 1.44
15 1 4 0.2500 1.69
17 1 3 0.3333 2.03
22 1 2 0.5000 2.53
23 1 1 1.0000 3.53
16
10 20
lig*4 Hazard plot (H(t) against t) for the data of 
Table 1, with straight lines fitted by eye.
Figure 4 shows the hazard plot for the data of 
Table 1, using linear scales. There is nothing in the 
diagram to contradict the assumption of an exponential 
distribution of failure times. Prom the graph, the
A
estimated ratio of hazards is
In Figure 5 the same hazards are plotted on a log
A
scale (that is, log^H(h) is plotted against log^k on a
linear scale), as for an underlying Weibull distribution.
It appears entirely reasonable to fit parallel straight 
lines, and when this is done the estimated index is found 
to be 1.2 . It is not possible by this method to esti­
mate the significance of the departure from the value 1. 
Taking intercepts from the graph,
y,o - -I u
I"Z 0^9,0 —  -I 08
17
jj
<r
/ • o
Fig. 5 Hazard plot (log,oH(t) against log^ t^) for the data 
of Table 1, with parallel straight lines fitted 
by eye.
. , 18 .
Hence 1*2 , so that 3.4, and the
I / \ I ^  I
estimated ratio of hazards is (3.4) = 4*4- •
2.2 Simple nonparametric methods of comparison
It is helpful to those.who have to interpret the 
results of a comparative study or an experiment if the 
comparison can be expressed in terms of a single figure, 
where it is reasonable to do so. Such figures are also 
useful for pooling the results of several studies. In 
the case of the exponential and Weibull distributions, 
the constant ratio of hazards provides this simple and 
readily-understood comparison. In this section, we 
consider three simple methods of comparison which do not 
rely on any assumption of the precise form of the 
distribution. One basic condition for the use, on its 
own, of such a summary is that there should be no 
crossing of the survival curves.
Comparison of the proportions surviving for a 
pre-determined period
By the PL method, equation (1.8), the proportions 
surviving at any pre-determined time t may be calculated 
for the two samples separately. Note that this method 
makes use of the survival experience of subjects whose 
survival times are censored. A variance may be calcula-
A
ted for ( j = 1,2) by taking the logarithm and
treating the proportion surviving in each interval as a 
binomial variable with expected value equal to the 
observed value. These variances may then be combined
19
and used in a comparison of the two proportions.
The standardised mortality ratio
Rather than comparing the survival distributions at 
a single point of time, it seems sensible to use for 
comparison a single figure which summarises the experience 
of each group over the whole observation period. Where 
numbers of subjects are large, one of many possible 
figures is the standardised mortality ratio (SMR), using 
the combined sample as standard population.
Let the total observation period be divided into 
arbitrary intervals as in  ^ 1.2 . For the Lth interval 
we have :
No. failing No • surviving Total
Group 1: mti
Group 2:
fuz
Combined
sample: N ,
Then for Group j, , according to the experience of the 
standard population, the expected number of failures is
Ti
SMR = Observed deathsy * *" Expected deaths '
SMH, = Imti .
L / L ' -r.- /
This is a weighted sum of the ratios /  f t  of
proportions failing per period, with weights M i n i • The
T i
comparison of SMRs will therefore be sensible if these 
ratios are reasonably constant over the total observation 
period. A preliminary inspection of the ratios should be 
carried out to make sure that this is the case.
20
Where numbers are small, such an inspection is 
unlikely to produce a satisfactory result. However, it 
will be shown in  ^2#3 that the SMR has a particular 
meaning for survival data which justifies its use, in 
many cases, even for small samples.
Pooling the separate time intervals
Mantel (1966) points out that a method devised by 
Mantel and Haenszel (1959) for use in retrospective 
studies of disease may also be used to compare survival 
data. Again, the total observation period is divided 
into arbitrary intervals as in  ^ 1.2, and a contingency 
table formed for each:
No. failing No. surviving Total
Group 1: me. f Û - m u n-,
Group 2; r m j z rcn
Total: M u M l T i
Given the risk sets and the number dying in the i th
interval, under the null hypothesis of a common survival
distribution is distributed hypergeometrically with
expected value . and variance \/(mq) = ^ ^ ^ .
‘ Û 1% (Ti.-1 )
Combining over all the tables, the continuity-corrected
statistic
X
is then distributed approximately as %  with one degree 
of freedom.
If observation is continuous, the time intervals may 
be made arbitrarily small. Then the tables which
21
contribute to X  correspond to times of single 
failures, so that Mu =1 or 0, or 1, M[=l and /Vi = T^-l
Then E l i l  and VfmcJ - liili?-.. .
 ^ Tc  ^ T i^
j^" “ are the conditional probabilities of
f a i l i n g  i n  th e  L th  interval, the odds r a t i o
is estimated by -- — - / — Eli!— , As a summary measure
rti- mci / ru -  mu
of relative risk. Mantel and Haenszel suggest
H  _ (2.2)
Z__ mci (rc;L-' MCz.;/ / L
OHiis may be expressed as a weighted average of estimated 
odds ratios, and has the advantage that zero entries 
present no problem.
For survival data, however, a more suitable measure 
of relative risk is the ratio of hazards, which is con­
stant for the exponential distribution and for the 
Weibull distribution with common index. Where numbers of 
subjects are large this is estimated 1,2) by
f which suggests that (2.2) might bej
;
replaced by
/ \ i . (2.3)
For small numbers and near-continuous observation (^ 1.2) 
/  ■—  is  the ratio at t i  o f the discrete ML estimates\ vZ / III
Of hazard. If this is used, (2.2) becomes
^  •
For the data of Table 1, (2.2) gives %% 5.2, while
22
(2.4) gives = 4.8 .
If only one failure occurs at each -hi , (2.2) and
(2.4) are identical, as 0 when rvi^i = 1 and vice-versa.
2.3 Nonparametric models with proportional hazards
By analogy with the exponential and VVeibull distri­
butions, we are interested in alternatives to the null 
hypothesis of a common survival distribution in which the 
ratio of hazards is constant. By (1.2), the survivor 
functions may then be expressed as 3^ (^b) . Such
alternative distributions are known as Lehmann alter­
natives.
The use of Mantel's procedure against Lehmann alternatives 
It may he shown (Radhakrishna, 1965) that the test 
based on Mantel’s X  is highly efficient against 
alternatives for which the odds ratio (see ^2.2) is 
constant over all contingency tables. Where numbers are 
large and each /V)y small compared with , the estimated 
odds ratio   —  is sufficiently close to the/ iTû- mil
estimated ratio of hazards --- —---  / ---^—  for the
test to be efficient against Lehmann alternatives.
For small numbers, it will be shown below in the 
discussion of Cox’s model that the models with propor­
tional odds ratio and proportional hazard are equivalent 
where observation is continuous. Where there is grouping 
leading to large numbers of ties this is no longer true, 
and it is expected that the test based on will be 
relatively inefficient against Lehmann alternatives.
23
The logrank test of Peto and Peto
Peto and Peto (1972) suggest a test of the null
hypothesis of a common survivor function (^b) against
Lehmann alternatives , 3"^ (^t) for the two groups.
Suppose 3(t) is known and we are interested in
finding '0,. By 6 1.1, the contribution to the likelihood
1.8,-I)
from a Group 1 failure at time t is 9| 3* (t)> and from a
censoring at time is total log likelihood
L is a sum of terms 9^|t‘B,6^ 3(t), 0, Cn3(t’^), so that ^  is ad
sum of terms Cn
Gi
dh.The ML estimate of 9| is found by putting = 0.
According to the null hypothesis, ^ when Bj = 1.
If scores U ^ failure 1 occurs at bû
I if a censoring J
are attached to the observations, the expected value of
X = X U  L i-8 zero under the null hypothesis. Exact
Croi^j I
significance levels for X may be calculated by 
randomisation methods, assuming censoring to be indepen­
dent of group membership.
In practice, &\ !}(ti) will not be known and must be 
calculated from the data. Remembering that 3-Ct) is the 
common survivor function under the null hypothesis, 
may be estimated from the combined data by (1.8) and the 
logarithm taken. Alternatively the first-order 
approximation, from (1.8),
U  §(tj - Z f l
U l  ^ &<L t
usually eases the computation considerably, and this is
the method suggested by Peto and Peto. The quantity
A
is the same as the joint estimate H (bjof cumulative 
hazard from (1.10). The scores become
24
r 1 " X. /rp ) if a failure 1
\\j: = J > occurs at tL.
[ —  X  n  ) if a censoring J
Where there are no ties, the VVl depend only on the 
order in which failures occur, so the test based on them 
is rank-invariant; it is known as the logrank test.
R. Peto (1972) shows that the exact tent based on the Vll 
is of maximal local power among all rank invariant tests, 
against Lehmann alternatives. It must, however, be 
emphasised that this locally most powerful test relies 
on the censoring being independent of group membership, 
which is seldom the case.
If censoring is not independent of group membership, 
provided we keep the convention of ^ 1.1 that a censoring 
cannot coincide with a failure, it is possible to show 
that %  may be treated as a sum of hypergeometric 
random variables. Peto and Peto suggest a method of 
calculating the significance level using Pearson curves. 
Alternatively, they suggest the calculation of a approxi­
mate X) statistic ^  where 0; = observed number
‘ ’ J
of failures, Groupj , and Ej = expected number of failures 
calculated under the null hypothesis: Ej = Zj C"“ ,
where summation is over all times of failures or 
censorings for Group j . (Note that ^  and Oj-Ej are 
equivalent.) The first of these procedures is time- 
consuming, the second rather rough.
As an estimator of 9j , the relative incidence rate 
for the J th group, Peto and Peto suggest That
this is a reasonable procedure may be shown as follows:
25
 ^ 9'(':c)] = i L  (t,)] (2.5)
Define = C 1 if a failure ) occurs at time t;.
[ 0 if a censoring j
If is known, the ML estimator of 0; is
Replacing by its estimator 3^(fci) and substituting in
A Oj(2.5) gives Ej i  -gj . so di ^
Although calculated differently, this is in fact the 
SMR for the j. th group. To show this, we use the notation 
of & 2.2 and write - Cn 3"(ki) = ZL ,
so that jr . T  - T  .
Once a typical term ^  appears in the summation, it
'e
re-appears for every subsequent failure or censoring from 
Group j ; that is, the number of ^  is precisely the 
number r,; of Group j subjects at risk at time L . Hence
and 0,i
This shows that the use of the SMR is meaningful 
even for small samples if there is reason to suppose the 
hazards proportional. The ratio of hazards is estimated
Illustration: The calculations for the W-scores for the
data of Table 1 are shown in Tables 3 and 4.
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Table 3» Calculation of In 5(t), under the null hypothesis 
of a common survivor function, for the data of 
Table 1.
bl mi r i "/ri
1 42 2 0.0476 0.0476
2 40 2 0.0500 0.0976
3 38 1 0.0263 0.1239
4 37 2 0.0541 0.1780
5 35 2 0.0571 0.2351
6 33 3 0.0909 0.3260
7 29 1 0.0345 0.3605
8 28 4 0.1429 0.5034
10 23 1 0.0435 0.5469
11 21 2 0.0952 0.6421
12 18 2 0.1111 0.7532
13 16 1 0.0625 0.8157
15 15 1 0.0667 0.8824
16 14 1 0.0714 0.9538
17 13 1 0.0769 1.0307
22 9 2 0.2222 1.2529
23 7 2 0.2858 1.5387
Table 4» Calculation of the Peto and Peto W-scores for 
the data of Table 1.
1---- --- -
bl Wi
1
tl Wi
6 1 - 0.3260 1 1 - 0.0476
6 1 - 0.3260 1 1 - 0.0476
6 1 - 0,3260 2 1 - 0.0976
6* - 0.3260 2 1 - 0.0976
7 1 - 0.3605 3 1 - 0*1239
g# - 0,5034 4 1 - 0.1780
10 1 - 0.5469 4 1 - 0.1780
10^ - 0.5469 5 1 - 0.2351
11^ - 0.6421 5 1 - 0.2351
13 1 - 0.8157 8 1 - 0.5034
16 1 - 0.9538 8 1 - 0.5034
17^ - 1.0307 8 1 - 0.5034
19^ - 1,0307 8 1 - 0.5034
20^ - 1.0307 11 1 - 0.6421
22 1 - 1.2529 11 1 - 0.6421
23 1 - 1.5387 12 1 - 0.7532
25* - 1.5387 12 1 - 0.7532
32^ - 1.5387 15 1 - 0.8824
32* - 1.5387 17 1 - 1.0307
34* - 1.538? 22 1 - 1.2529
35* - 1.5387 23 1 - 1.5387
9 -19.2505 21 -10.7494
qrDO|?) ' qroujal
denotes a censored observation)
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A g
= iS-<25 (Relative incidence rate)) 0-4.7
0^ =llj I0'75 (Relative incidence rate)^  ^=
A
The ratio of hazards is estimated by db
éi
Although shown here for interest, this method of 
calculation is seldom used in practice, as the W-score is 
the same as Cox’s U (o) (see below), and the use of Cox’s 
formula is computationally simpler.
Cox’s model
Cox (1972) proposed a regression model for hazards 
which will be considered more fully in ^3. In the two- 
sample case, given that observation is continuous, this 
reduces to
X.(t) = Ao(t) I (2 6)
where \>(b) is an arbitrary function of t . This is 
simply the model with proportional hazards.
It is not possible to obtain the full likelihood for 
without specifying . Cox obtains a partial
likelihood by a somewhat intuitive argument. Given that 
a failure occurs at the probability, conditional on
the set of subjects at risk at t l ,  that the failure
is on the individual as observed is
r -----L_  if the failure is from Group 1
h  = 1 a,
+ e/3 riz ff the failure is from Group 2.
Multiplying the leads to the log-likelihood
N
LÇâ) =  ^ ( r \ ( r c ,  +e.1 r^:^) (2.7)
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where is the number of failures from Group 2 and hi is 
the total number of failures.
It is questionable whether the may be regarded as 
independent, since (R. (be) depends on the outcome at all 
previous failure times. However, a rigorous justifi­
cation of the full regression model version of (2.7) as a 
marginal likelihood is given by Kalbfleisch and Prentice 
(1973). Conditions for this justification in the two- 
sample case are that XJb) is never zero over an open 
interval and y3 is independent of t .
The derivatives of (2.7) are
-  f f  -
and
^  ^  - Z
Cox points out that it is not possible to calculate 
the expected value of (2.9) without making assumptions 
about the potential censoring times of individuals who 
were not censored. However, without making such 
assumptions it is possible to derive an approximate test 
of the null hypothesis of equal hazards by treating U(o) 
as asymptotically N (o , ^ (0)).
If ties are present in the data, the partial 
likelihood is less easy to obtain. Cox’s approach has 
been much criticised, and several authors have proposed 
alternatives. Cox treats time as discrete, so that A(0 
becomes the conditional probability of failing at time t . 
As it is now possible for more than one subject to fail 
at time , the partial likelihood must now be made
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conditional also on the number of failures a t  h i .
Cox replaces (2.6) by
-  Ao lb )  I
 ^  Ao(t1 f (2.10)
I -  X i[k) I -  Xo(t) J
which is a model for proportional odde-ratios. The
reason for this rather unexpected step is simply
convenience. Suppose for example that = 2 and Q % =  3
Given that one failure occurs at the probability that
this is on the individual as observed is now unpleasantly
complicated. However, we can write down the probability
that the failure is from Group 1, which is
b- - 2. X,(fci)Q - X^lku)]
ZXi(ki)[l-A;^(t0j + 3Xi,(ti,)[i-X|(ti)]
Use of (2.10) makes this independent of whereas
(2.6) does not.
In general, is the probability, given M l failures 
at (rL, that, as observed, rhu of these are from Group 1 
and from Group 2. Cox’s partial likelihood consists
+ e^mVz.)
where summation is over all distinct sets of Mi subjects 
drawn from the risk set at time t i ,  and in any given set 
M i| of these are from Group 1 and 41a from Group 2. This 
leads to
k
U(o) = hx- Z  MtAi. (2.11)
i-l
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and (^0) c V  — - ' J  (2.12)
N  U - I
where Ai = is the proportion of the risk set in 
Group 2 and k the number of distinct times of failure.
If Ml = 1 for all L, this gives the same result as 
(2.8) and (2.9).
The test is formally identical with that of Mantel 
(^2.2), as may be shown by a slight change of notation. 
(The Cox statistic does not include the continuity 
correction.) This is not surprising, as both follow from 
the assumption of proportional odds ratios. Less obvious 
is the fact that U(o) is identical with the Peto and Peto 
statistic W  t . It was shown above that £, -7 ;qfoaj|> 3.  ^ I I U
hence £[ Wv = O^'E, = -U(o).
I 'I
If the lAifj are all small compared with the r^' , or if 
the grouping of continuous time is slight, the Xt) in (2.10) 
are small and (2.10) approximates to (2.6). This is not 
so if there are many ties amongst a small set of data; in 
this case the model with proportional odds-ratios departs 
considerably from that with proportional hazards, and one 
of the alternatives outlined below might be preferred.
Cox demonstrates the calculations for (2.11) and
(2.12) on the data of Table 1, obtaining U(0) = 10.25 
(as we obtained in Table 4 for the sum of the W-scores) 
and i(o) = 6.257 • Estimation of /3 involves iterative 
solution of the ML equation. Cox obtains, for these data,
A
p> = 1.65, giving t  = estimated ratio of hazards = 5.21 .
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Perhaps not surprisingly, this is close to the pooled 
estimate of odds ratio from equation (2.2).
Alternatives to Cox’s method of dealing with tied data 
Kalbfleisch and Prentice (1973) treat tied data as 
the result of approximations in the measurement of 
continuous time. If subjects are recorded as failing 
at time , they assume that these failed in some order 
unknown because of the grouping of the time-scale. There 
are nnj possible orders of failure, each of which 
contributes to the partial likelihood, which becomes a 
product of k sums of rDj,! terms ( L= l,2,...,k). Whilst 
this approach is intuitively appealing, the likelihood is 
complicated to write down, and does not lead, in the two- 
sample case, to a simple formula for variance to replace
(2.12). The resulting ML estimate of is likely to be 
closer to the true ratio of hazards, rather than the odds 
ratio. Kalbfleisch and Prentice illustrate this using 
grouped simulated data from exponential distributions.
For the data of Table 1 they obtain ^  = 1.59, so their
a
estimate of the ratio of hazards is 6^= 4.9.
Breslow (1974) derives a form of the log-likelihood 
which approximates to those of Cox and of Kalbfleisch and 
Prentice, but is much simpler. For two groups, the 
derivation is as follows. From (2.6) and 1.2, ML 
estimates of hazard give discrete hazards with values at ll
\ ma
estimated by --^   —  *' tl r ti.
32
Combining these with weights equal to the numbers at risk 
leads to the joint estimate
^ --- • (2-13)
Since this also estimates the probability of failing at
time t'l, the log-likelihood is
N
L(/s) = n y i +  . (2.14)
For testing the null hypothesis of equal hazards, this 
gives the same statistic U(o) as Cox’s method, but with 
variance
f(0) = Z  fllO-fli) (2.15)
i-l
This is slightly larger than j(o ) and less likely to lead 
to a falsely significant result where ties are many.
The likelihoods of Cox, Kalbfleisch and Prentice, 
and Breslow are identical where there are no ties.
2.4 Further discussion
Estimation of the underlying survivor function
Various methods are suggested by Cox, Kalbfleisch 
and Prentice, and Breslow for using the combined data to 
obtain an estimate of the underlying survivor function 
based on the unspecified hazard Xyt), Breslow’s is the 
most straightforward. Combining the discrete hazard
A
estimates (2.13) and r e placingby its ML estimate yS 
Gives a  L \
3 ( t o  = U  ( '  - r Z T k Z  )  • (2.16)
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The hazard is smoothed by taking it to be constant between 
failure times. Then, since (2.13) represents the increase 
in cumulative hazard over )bj, if all censorings in 
the interval [t(,-ptc) are adjusted to occur just before 1:^-1, 
the estimated hazard is given by
(trtn )\(t) = ^ ^
A
Values of 3 (b^) plotted using (2.16) are then joined by 
straight lines.
Departures from the model of proportional hazards
If the survival curves cross, so that the short-term 
prospects for survival are better for one group and the 
long-term prospects better for the other, it is absurd to 
try to sum up the differences in survival by a single 
comparison. Plotting the two estimated survivor functions 
or cumulative hazards on one graph will reveal any 
important crossing-over. If the cross-over occurs early 
in the observation period, it may be caused by some 
incidental factor such as post-operative deaths. The 
measurement of survival time might then be started from a 
later point to allow for this.
Where there is no crossing of the survival curves, 
two kinds of departure from the model of proportional 
hazards are common. If a treatment for a disease which 
causes high mortality is successful, the death rate for 
the successfully-treated group will decrease with time 
until it reaches that of the general population. If the 
treatment is moderately successful, it may cause the
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postponement of the deaths of a proportion of patients 
who would otherwise have died early in the observation 
period. The death rate for the treated group will 
initially be lower than that of the control group, but 
will later increase sharply until it reaches that of the 
untreated patients. Either of these cases may be treated 
parametrically by fitting Weibull distributions with 
different indices, but the amount of computation involved 
is considerable. Small amounts of data, for which the 
shape of the survival curve is not well-defined, seldom 
justify such elaborate treatment.
For a simple comparison of survival between two 
groups, the choice lies between the exponential model and 
methods based on the work of Cox, Peto and Peto, and 
Mantel and Haenszel. If the hazards do not appear to be 
proportional, they will certainly not both be constant; 
the test for equality of hazards using Cox's standardised 
normal deviate seems the most reasonable one to use in 
this case. The quantity may still be calculated and 
quoted as an overall measure of group effect; alternative­
ly, the Peto and Peto relative incidence rate (SMR) may be 
used. The latter is more easily found as iteration is not 
required, and the necessary calculations are included in 
the calculations for U(o).
Cox suggests that departures from the model of 
proportional hazards should then be investigated graphical­
ly. The underlying survivor function is estimated; we 
suggest Breslow* s estimate (2.16). Estimates for the tv/o 
groups, such that the fitted hazards are proportional, are
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given by (2.16) for Group 1, and by
A
= [5 (tl)]
for Group 2. These may be plotted on one graph with the 
separately-estimated survivor functions, when any marked 
departure from the model of proportional hazards becomes 
apparent.
Cox's paper includes such a graph for tiie data of 
/\
Table 1, based on XqI found by his own iterative method.
A similar graphical investigation is suggested by the 
form of the model used by Peto and Peto, and the resulting 
graph is shown in Figure 6 for the data of Table 1. The
-3
Fig.6 Log survival curves for the data of Table 1.
XX, • • separate estimates of
—  ,---  estimates constrained by proportionality
(for clarity, these are joined by straight lines)
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A
combined data provides an estimate of £a 3-(U) > as in
A  A
Table 3. The relative incidence rates ©, , for the two 
groups are then found, and the estimates for the two log 
survivor functions
k  i l b j  = ©, In 3 - ( t 0 , Ù. = ê ^ U 3 ( b i )
are such that the hazards are proportional. This method, 
whilst it is simpler, is less refined than that suggested 
by Cox, as the joint estimate of survivor function is 
based on the null hypothesis of a common hazard for the 
two groups, rather than the alternative of proportional 
hazards.
Although the plotting of such graphs may be useful as 
a clear way of presenting the results, it is seldom 
essential in order to see whether the hazards are propor­
tional. When the latter is true, we may write the log 
survivor functions as
3-(t ) , B tn 3- ( h ) .
A plot of the survival curves using a log scale (or, 
equivalently, a hazard plot) will usually be sufficient to 
reveal any important difference in shape, especially if 
one of the hazards is nearly constant.
2.5 Comparison of more than two samples
If the hazards may be assumed constant, the ML and 
hazard-plotting methods extend straightforwardly to any 
number of groups. The fitting of Weibull distributions 
with a common index leads to heavy computation or to the 
problem of fitting several parallel straight lines by eye
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to sets of plotted points.
Extension of Mantel's method of pooling leads to the 
consideration of an sX2 contingency table for each time— 
interval, where s is the number of groups. The compu­
tation involved is heavy (Mantel and Haenszel, 1959)» and 
if the groups correspond to different levels of a factor, 
such as age or dose of a carcinogen, a more sensible first 
approach would be to form 2x2 tables for the two extreme 
levels and test for significance of the difference between 
these levels.
The approximate test of $2.3 was originally
suggested by Peto and Peto for testing for treatment effect
s
between several groups: X  } may be tested
against the a- distribution. The relative incidence 
O' /rates are calculated just as in the two-sample case,
and may be used to pinpoint the treatments responsible for 
the differences (Roe et al, 1970).
2.6 Summary
The comparison of survival data for two groups of 
subjects is considered for the case where the groups are 
similar with respect to all factors other than the 
distinguishing factor. Numerical and graphical methods 
are outlined for the exponential and Weibull distributions 
of failure time; these lead to a simple comparison in the 
form of the constant ratio of hazards. Simple nonpara- 
metric methods described are the comparison of proportions 
surviving for a pre-determined period, the comparison of 
standardised mortality ratios, and pooling procedures.
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after Mantel, for a set of 2x2 contingency tables, one 
for each sub-division of the observation period. More 
sophisticated nonparametric methods, based on a model in 
which the hazards are unspecified but proportional, are 
those of Peto and Peto and of Cox. The test statistic 
proposed by Cox is shown to be identical to those of 
Mantel and of Peto and Peto, and the relative incidence 
rate suggested by Peto and Peto as a measure of group 
effect is shown to be the same as the SLIR. Alternatives 
to Cox's method of dealing with tied data proposed by 
Kalbfleisch and Prentice and by Breslow are considered, 
and Breslow's method of estimating the underlying survivor 
function is outlined. Graphical methods are suggested for 
examining the estimated survivor functions for departures 
from the model of proportional hazards. Extension to the 
comparison of several groups is briefly considered.
The methods are illustrated on a set of data quoted 
by Cox.
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3» The Inclusion of Covariates in the Model 
3.1 Underlying distribution exponential 
The two-sample case with single covariate
Suppose the subjects in the two groups differ 
markedly with respect to some variable, such as age, 
which might affect their survival. Allowance may be 
made for this by introducing a covariate into the model.
A natural extension of the model with proportional 
hazards assumes a multiplicative model for the hazards, 
as suggested by Glasser (1967). Suppose, for the ith 
subject in Group j ( j = 1,2), is the difference in his
age from the overall mean of the two groups. Let the 
hazard for this patient be X: . Then if all the
patients have the same age, this reduces to thé simple 
exponential model of $2.1. If not, the hazards for two 
subjects in the same group are proportional, the constant 
of proportionality depending on the difference in their 
ages.
The contribution to the log-likelihood L of the Ith 
subject in Group j is
if the subject fails at time ty , and
if the observation is censored at time (ry .
The ML equations are
I k - x O ;  li=-=0; - l k _ = 0 .
 ^X I  ^X  ^^
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These may be solved iteratively using Newton- 
Raphson methods. Glasser points out that the estimates 
of the Aj may be written explicitly in terms of the 
estimate of A at each iteration, which leads to some 
simplification. Convenient initial values are = 0,
~ (the estimates of X: from 6 2.1).
' I A t
An estimate of the covariance matrix for/3, A, and
may be obtained by inverting the 3x3 matrix of second
derivatives of L. W,e are interested first of all in
whether/3 differs significantly from zero. This may be
A
tested by comparing with the standard normal
vctxip)
distribution. Alternatively, the log-likelihoods may be 
compared for /3 and = O  , using the fact that
L(0) ] is distributed as with one degree of
freedom.
I f i s  found to differ significantly from zero, it 
is convenient to quote the value of p> together with its 
variance, and also the age-adjusted hazards A\ , A^ . The 
initial estimates X|^  ^ , X^ °' , ignoring age are also of 
interest, and may be quoted for comparison.
An alternative model assumes an additive effect for 
the covariate on the expected survival time of the sub­
ject. The hazard Xj is given by
X  - (^J + bxcj)''
Solution is again by ML methods; the models are equi­
valent to the first order in Xtj.
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Model allowing for interaction
So far, it has been assumed that the effect of age 
on survival is the same for the two groups. If it is 
suspected that this is not so, so that there is 
interaction between age and group effect, we may fit 
separately hazards , and teat for
g  = .
Peigl and Zelen (1965) give an account for the 
alternative model \j = [uj + by-Xtj)  ^ in the uncensored 
case; Zippin and Armitage (1966) extend this to the 
censored case, for a single group.
More than one covariate
Suppose we wish to compare a number of groups, or 
two groups for which more than one covariate may be of 
importance. The multiplicative model extends naturally 
to one in which the hazard for a subject with vector of 
covariate values Z , where j J . (Z,,Zi,...,Z^), is
V __ V
^ ^ (Model I)
where ^  is a vector of parameters and (/3| ).
If = 2, % I is a (0,1) variable to indicate group 
membership (an indicator variable), and is the 
deviation from mean age (a baseline variable), this is 
the same as the model with a single covariate: A, = Ao ,
^1 ~ ^  ^ third covariate may be included
to take account of interaction.
The model may again be fitted by Newton-Raphson 
iteration of the ML equations. Convergence is speeded if
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each. 7^ ( t = 1,2,...,^) is adjusted by subtracting from 
it the overall mean of the for all subjects. A 
convenient initial value for /3 is then = 0. The 
inverse matrix of second partial derivatives is again 
used to estimate the covariances.
Selection of the relevant covariates and testing the 
equality of treatment effects is then achieved by fitting 
submodels in which one or more covariates are eliminated, 
or one or more treatment groups pooled, and comparing the 
resulting log-likelihoods. (Twice the difference in log- 
likelihoods is distributed as X^with^ degrees of 
freedom, where j ' is the difference in the number of 
parameters being estimated.) The decision of which 
covariate2^ to eliminate at any given stage may be based on 
a comparison of the estimated parameter with its 
estimated standard error.
The alternative model may also be extended to more 
than one covariate as
X - X q (l i- z ! (Model II)
3»2 Gox's regression model
If it is suspected that the underlying hazard is not 
constant, we may write, for the hazard for an individual 
with covariate vector Z ,
z^ /3
-X (.tj z.) = Xo(h) X e (Model III)
where A^ Ct) is an unspecified function of t  • This is the 
full regression model which has (2.6) as a special case
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(Cox, 1972).
Where there are no tied data, the partial log- 
likelihood is
k k
where is the set of individuals at risk at time
G ox obtains this by the argument outlined in $ 2.3, and 
the justification by Kalbfleisch and Prentice (1973) 
mentioned there holds for (3.1) provided that A^(b) is 
never zero over an open interval, and all the are 
independent of time.
If ties occur among the failure-times, Cox's 
discrete-time model (2.10), in which A(t) is now the 
probability of failing at time t , becomes
1 -X(t) -  I -XoW
leading to the partial log-likelihood
(3.3)
where S[ is the sum of z over individuals failing at 
and the notation means that the sum is taken over all 
distinct sets of individuals drawn from
The procedure for selection of relevant covariates 
is similar to that for the exponential model ($3.1).
As in the two-sample case ($2.3), there are 
difficulties with the model where many ties are present
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in the data. The alternative treatments for ties 
proposed by Kalbfleisch and Prentice and by Breslow were 
outlined in $ 2.3 for the simpler case. In particular, 
for Breslow's treatment, (2.13) extends to
ol = —  '----  (3.4)
gaR.(lL)
leading to the log-likelihood
L(5) (3.5)
Again, Breslow*s method for estimating the 
underlying survivor function is the most straightforward, 
(2.16) extending to
3.4 Comparison of the three regression models
Breslow (1974) compares the three models for data 
from a clinical trial of maintenance therapy for 
childhood leukaemia. He finds little difference in the 
results for models I and II. Model III appears to be 
more powerful in this case for distinguishing the 
important covariates. This is explained when the under­
lying survivor function is plotted and found to depart 
from the exponential form over the early part of the 
observation time. Breslow concludes that the use of 
Model III is worth the slightly heavier computation 
involved.
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Breslow also compares estimates of the underlying 
survivor function calculated from Cox's original model 
(3#2), from (3.6), and by the actuarial method of $1.2 . 
He finds that for practical purposes there is little 
difference between these for the first sixty or seventy 
per cent of the observations. This suggests that an 
actuarial or PL estimate might be made and plotted at the 
beginning of the analysis as an aid in deciding between 
the exponential and nonparametric models.
The Cox model might prove especially useful as a 
substitute for the modified Weibull model for carcino­
genesis ($1.3). Since the survivor function proposed in 
the latter model is difficult to fit, it seems sensible 
instead to use a method which is independent of the 
precise form of the hazard function.
Cox's paper suggests that time-dependent covariates 
might be included in his model. This would be useful as 
the effect of a successful treatment tends to increase 
with time ($2.4). It is, however, difficult to justify; 
the marginal likelihood obtained by Kalbfleisch and 
Prentice is valid only when all covariates are 
independent of time. No such objection applies in the 
case of the exponential model.
3.5 Summary
The inclusion of a single covariate in the two- 
sample exponential model is considered in some detail.
The model is then extended to include any number of 
covariates. Cox's regression model, in which the form
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of the underlying hazard remains arbitrary, is presented 
as a similar extension of the model with proportional 
hazards of $2.3 • Reference is made to Breslow's 
comparison of these models.
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4. Analysis of a Body of Data
Table 5 gives the available data on 93 patients 
included in a clinical trial conducted by the Brain 
Tumour Study Group, M.D.Anderson Hospital and Tumour 
Institute, University of Texas. Failure times (in this 
case, times of death) after the start of treatment are 
given in days. There are few tied failure times, with no 
multiplicity greater than 3. The failure times of 3 
patients were censored; these patients were still alive 
at the end of the trial. Treatments were coded as 
follows:
Chemotherapy X-rays
0; control 0: none
1: treatment 1; between 0 and 3000 rads
2: between 3000 and 5000 rads
3: more than 5000 rads 
Additional information on each patient consists of 
duration of symptoms, presumably before the start of 
treatment, in weeks, age in years, sex, and location of 
tumour. . The latter is coded:
1: frontal 
2: temporal 
3: parietal 
4: occipital 
5: deep BG thalamic 
6 : other
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Table 5• Data on 93 patients included in a clinical trial.
Patient
Number
Failure 
Time 
(days)
Chemo­
therapy
X-rays Duration
of
Symptoms 
(weeks)
Age
(years
Sex Location
of
Tumour
1 10 0 0 7 46 M 2
2 12 0 2 56 56 F 3
3 15 1 1 9 57 F 1
4 18 1 1 3 39 M 3
5 20 1 0 9 60 M 1
6 21 0 0 24 52 M 6
7 22 1 1 32 60 F 1
8 25 0 0 50 53 M 1
9 30 1 0 14 54 M 6
10 32 1 2 8 57 M 1
11 34 0 0 13 72 M 3
12 37 0 0 19 55 M 3
13 41 1 0 27 67 M 1
14 42 0 0 73 40 M 5
15 46 1 0 14 52 M 2
16 49 0 0 8 57 F 1
17 51 0 3 76 60 M 5
18 51 1 0 60 56 M 1
19 54 0 0 10 40 M 5
20 56 1 3 37 68 F 1
21 57 1 3 14 59 F 3
22 59 1 0 15 36 M 1
23 62 1 2 21 46 F 2
24 64 1 0 19 56 M 3
25 71 1 1 22 60 M 1
26 72 1 2 13 53 F 5
27 79 1 0 15 40 M 4
28 82 1 1 25 45 M 3
29 85 1 0 22 43 F 2
30 97 0 0 23 48 F 1
31 102 0 1 47 52 M 4
32 107 0 0 43 71 M 3
33 108 0 0 18 50 M 3
34 119 0 0 187 48 M 1
35 121 0 0 23 57 M 1
36 129 1 3 24 59 M 2
37 131 1 0 19 59 M 1
38 132 0 0 42 49 M 3
39 134 0 2 44 60 M 3
40 .135 1 0 82 35 F 2
41 135 0 3 32 40 M 6
42 136 1 0 31 22 F 3
43 143 1 0 28 52 M 3
44 144 1 0 22 41 M 2
45 145 .1 3 23 55 M 2
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Table 5 (continued)
Patient
Number
Failure 
Time 
(days)
Chemo­
therapy
X-rays Duration
of
Symptoms 
(weeks)
Age
(years
Sex Location
of
Tumour
46 147 1 0 23 45 M 4
47 162 0 0 26 66 F 2
48 162 1 0 30 64 F 4
49 162 1 3 37 50 M 1
50 164 1 0 78 53 F 2
51 177 1 0 49 48 M 2
52 181 0 1 41 45 M 1
53 194 0 0 347 57 M 2
54 200 0 3 312 42 M 2
55 204 1 3 43 57 M 2
56 214 1 2 39 42 M 1
57 231 0 3 38 53 M 1
58 234 0 2 40 60 F 3
59 248 1 3 39 51 F 3
60 252 0 3 39 31 M 2
61 253 0 3 48 47 M 2
62 253 1 3 62 73 M 6
63 255 1 3 40 53 M 3
64 255 0 2 48 70 M 2
65 259 0 0 99 44 M 1
66 264 1 2 42 53 M 1
67 272 1 0 41 55 F 2
68 2(2 0 3 41 30 M 4
69 274 1 2 42 47 M 2
70 275 1 0 44 56 F 3
71 281 1 2 43 66 M 1
72 297 0 3 50 54 M 2
73 298 0 0 49 51 M 1 3
74 325 0 3 59 56 M 2
75 336 1 3 153 58 M 1
76 345 1 3 76 52 M 2
77 347 1 2 80 57 M 1
78 359 0 2 57 55 M 1
79 385 0 3 59 59 M 2
80 387 0 3 54 45 F 6
81 408 0 3 85 36 M 3
82 410 1 2 14 68 M 1
83 449 0 3 71 58 M 4
84 466 1 3 140 40 F 2
85 475 0 2 71 57 M 4
86 484 0 0 84 50 M 1
87 495* 0 1 90 53 F 2
88 522 1 3 96 52 M 1
89 526 0 2 87 59 M 2
90 669 1 2 121 47 M 2
91 815* 1 3 168 22 M 1
92 847* 1 3 400 48 F 2
93 1760 1 3 253 27 M 1
(* denotes a censored observation)
50
There was no random allocation of treatments to 
patients so chemotherapy and X-rays are to be treated as 
factors in the same way as age, duration, etc. The 
problem is to disentangle the effects of the factors on 
survival.
The use of Cox*s regression model is suitable for 
data of this kind, since there are several factors of 
interest, and the data are too few for a satisfactory 
breakdown into homogeneous subgroups. However, the 
computation involved in applying Cox's method with a large 
number of covariates is very heavy. Our purpose here is 
to demonstrate the methods of ^2 in the kind of analysis 
which might usefully be done before embarking on the use 
of the full regression model, in order to suggest which 
factors should be included.
4.1 The overall survival curve and marginal distributions 
of survival time
As there are few censorings, the PL method (^1.2) is
A
the simplest way of estimating 3* which is equal to 
the proportion surviving for most . Figure 7 shows 
these values for the whole data, plotted on a log scale; 
points are plotted for the last two censored observations
A
as a reminder that 3"(b ) does not become zero within the.A
time-scale used. The exponential curve 3‘(^ ) = C , where
A
A is found using equation (1.11), is also shown; the fit 
is quite good, although the hazard does appear to be 
increasing slightly.
For Figure 8, subjects are grouped according to the
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amount of X-rays received. X-rays 1 and 2 are pooled 
because only 8 patients received X-rays 1. For the most 
part the curves lie above one another, but there is a 
marked departure from a straight line for X-rays 3. This 
suggests that non-parametric methods might be preferable 
to fitting an exponential model when comparing subgroups 
of the data.
For the purposes of a preliminary analysis, duration 
and age need to be broadly grouped. After examining the 
distributions of these, it was decided to group as 
follows:
Duration (weeks) 0-29 30-69 70 and over
(Low, L) (Medium, M) (High, H)
No. of patients 33 37 23
Age (years) 20-49 50 and over
(Low, L) (High, H)
No. of patients 33 60
Only Locations 1, 2, and 3 included sufficient 
patients (30, 28 and 19, respectively) for a separate 
comparison between these locations to be possible.
Marginal distributions of survival were examined by 
calculating G ox’s U(o) (2.11) and j[0) (2.12) for two 
suitably-chosen groups, and combining these to obtain a 
continuity-corrected standardised normal deviate (SND). 
The results are shown in Table 6, together with the Peto 
and Peto relative incidence rates for the two;
groups in each case.
The important factors appear to be X-rays and
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Table 6. Calculation of standardised normal deviates and 
relative incidence rates for marginal 
distributions.
Factor Levels 
for two 
groups
Number
of
deaths
Expected no. 
deaths, Gp 2 
(E^= E M c A J
Variance SND 0
Chemo­ 0 41 1.00
therapy 1 49 49.0549 21.5468 0.09 1.00
X-rays 0 39 1,86
1,2,3 51 68,9894 14.5196 -4.72 0.74
Duration L 33 2.15
H 20 37.6294 8.5839 -5.85 0.53
Age L 31 0.87
H 59 54.4762 20.2551 1.01 1.08
Sex M 69 0.99
F 21 20.0887 15.4328 0.10 1.05
Location 1 29 1.11
2 26 28.9326 13.3435 -0.67 0.90
Location 1 29 0. 87
3 19 14.5671 9.4205 1.25 1.30
duration of symptoms, but it is clear at a glance from 
Table 5 that these are related. Although no other factor 
appears to have a significant effect, it is possible that 
dependencies between the factors are obscuring such 
effects. For example, since high duration of symptoms 
apparently confers a survival advantage, the fact that 
few older patients have high duration might obscure an 
advantage due to age. The next step is to examine two- 
way distributions of all pairs of factors; this reveals a 
number of possibly important dependencies.
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4.2 Two-way distributions excluding survival 
Sex; All factors except location and chemotherapy are 
distributed independently of sex, and in view of the non­
significant result in Table 6 it was decided to pool the 
sexes when considering all other factors.
Age : All factors except duration of symptoms appear to
be independent of age. Table 7 shows the agexduration 
distribution. There is a lack of high durations amongst 
the older patients; possibly such patients have died 
without being presented for treatment.
Table 7. AgexDuration
Duration L M H Total
Age ^ 1122
11
26
11
12
33
70
Total 33 37 23 93
Location: Both chemotherapy and X-rays are unbalanced
over locations. There is also a lack of high durations 
for Location 3, as shown in Table 8.
Table 8. Lo c at i onxDurat ion
Duration L M H Total
1 11 11 8 30
2Location ^ 88
10
10
10
1
28
19
4,5,6 6 6 4 16
Total 33 37 23 93
Duration: The lack of independence of age and duration
ha already been mentioned. Because of the lack of 
randomisation to treatments, a high proportion of 
patients with low duration received chemotherapy, and a 
similarly high proportion were not treated with X-rays.
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About 40^ of patients with Durations M and H received the 
highest dose of X-rays, as opposed to roughly 10;^  of 
patients with Duration L.
Table 9. ChemotherapyxDuration
Duration L M H Total
Chemotherapy ^ 1023
20
17
12
11
42
51
Total 33 37 23 93
Table 10. X-raysxDuration
Duration L M H Total
0 22 10 7 39
X-rays 1,2 8 12 5 25
3 3 15 11 29
Total 33 37 23 93
Treatments ; Although treatments were clearly non­
randomised, it is difficult to see any reason for the way 
in which they were allocated; their distribution over the 
other factors appears haphazard. Chemotherapy and X-rays 
do, however, appear to be independent of oneanother.
4*3 Comparisons of survival for pairs of factors within 
different cells 
Important dependencies are all between duration and 
another factor. The effects of duration and X-rays are 
confused, and effects of age, location and chemotherapy 
may be obscured due to the lack of independence between 
duration and each of these factors. In an attempt to 
disentangle the effects of the other factors from that of 
duration, comparisons of survival are now made within 
cells of the two-way tables of ^4.2.
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Once again, the Cox SNDs are calculated as a test of 
the equality of survival probability between two groups. 
The relative incidence rate is again given as an indi­
cation of the size of an effect, although in some cases 
numbers are so small that this is only a very rough guide.
X-raye and Duration: It is evident from Table 6 that
these are the main factors affecting survival, and 
Table 10 confirms the impression,gained from Table 5, that 
they are related. As neither is very closely related to 
any other factor, we may ignore the other factors when 
assessing the effects of X-rays and duration.
Numbers are such that we may reasonably compare the 
effect of X—rays versus no X-rays for pooled Durations M 
and N, but the comparison must be made separately for 
Duration L. The results are shown in Table 11. The 
effect of X-rays appears to be significant for Durations 
M and H, but not for Duration L. However, this apparent 
interaction might be due to the higher proportion of 
patients with durations M and H who received X-rays 3.
Table 11. SNDs and relative incidence rates for X-ray 
contrasts.
Duration X-rays Number of 
deaths
SND
%
L 0 22 1.05
1,2,3 11 12.0135 7.1310 -0.19 0.92
M and H 0 17 1.56
1,2,3 40 48.3301 6.9431 -2.97 0.83
Any attempt to refine this crude analysis further 
introduces a common problem in statistics. In any further
58
sub—division, the numbers in the groups become very small. 
Tests based on them will be unreliable, and examining all 
possible contrasts greatly increases the chance of 
obtaining a falsely significant result. It is at this 
stage that a regression model would provide the best 
method of proceeding with the analysis.
Comparisons of duration effect were made between 
Duration L and pooled Durations M and H for the groups 
with X-rays 0 and with X-rays 1 and 2 respectively.
Numbers do not permit such a comparison to be made for 
X-rays 3. The results are shown in Table 12 and indicate 
a comparable duration effect for both X-ray groups.
Further breakdown into subgroups raises the problems 
already mentioned in connection with X-rays.
Table 12. SNDs and relative incidence rates for duration 
contrasts.
X-rays Duration Number of 
deaths *o)
Sim
%
0 L 22 1.81
M and H 17 26.8734 6.8352 -3.59 0.63
1,2 L 8 2.15
M and H 16 20.4415 2.7870 -2.36 0.78
The shapes of the survival curves for the various 
subgroups are interesting, and four of these are shown in
A
Figure 9. Here (PL estimate) is plotted, for
Durations M and H separately, for the highest and lowest 
X-ray groups. With X-rays 0, there is no clear 
distinction between the curves for the two durations.
The curve for X-rays 3, Duration M shows an "elbow"
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followed by a sharp decline, which suggests an initial 
advantage for patients receiving this treatment. For 
Duration H, the curves for the two X-ray levels are well- 
separated. Although any conclusions from such small 
numbers must be tentative, the graph does appear to 
support the impression of an interaction between X-rays 
and duration, and suggests that X-rays may have a long­
term effect only for patients with high duration of 
symptoms.
Age ; The numbers in Table 7 indicate that the survival
distributions for age may be compared for pooled Durations
L and M, but a separate comparison is necessary for 
«
Duration H. For each of these pairs of groups, a check 
was made of the two-way distribution with chemotherapy. 
X-rays and location. Only in the last of these was any 
marked dependency found: for Durations L and M, a 
majority of the tumours at Locations 1 and 3 are found 
among the older group of patients.
Results of the comparison are shown in Table 13. No 
effect of age on survival is apparent.
Table 13» SNDs and relative incidence rates for age 
contrasts
Duration Age Number of 
deaths (^o)
SND
M,L L 22 1.06
H 48 49.2222 14.0998 -0.20 0.98
H L 9 0.83
H 11 9.2117 4.3408 0.62 1.19
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Chemotherapy: The proportions of patients with Durations
M and H receiving chemotherapy are similar (Table 9), so 
it is reasonable to pool these durations for comparison:
Duration L M and H Total
Chemotherapy ^ 1023
(Gp A) 
(Gp B)
32 (Gp G) 
28 (Gp D)
42
51
Total 33 60 93
Before comparing A with B and C with D, checks were 
made on their two-way distributions with other factors.
It was found that no members of Group A received any 
X-rays, so Group B patients receiving X-rays were ignored 
in making the comparison, leaving 12 Group B patients. 
Locations were independently distributed over the 
resulting groups. X-rays were independently distributed 
over Groups C and D, but D showed some lack of Locations 
3 and 4,5,6.
The results of the comparisons are shown in Table 14. 
There is no evidence that chemotherapy has any effect on 
survival, although it is impossible to disentangle the 
effects of chemotherapy and location because of the very 
small numbers in comparable groups.
Table 14. SNDs and relative incidence rates for 
chemotherapy contrasts.
Duration Chemo­
therapy
Number of 
deaths Ex EM; 4; k o )
SND
%
L, with 0(A) 10 1.08
X-rays 0 1(B) 12 12.7146 4.9066 -0.10 0.94
0(C) 31 l.l3
1(D) 26 29.6451 13.3893 —0.86 0.88
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Location; Table 6 shows no significant difference 
between survival distributions for Locations 1 and 2.
As two-way tables for location with each of the other 
factors show them all reasonably independent of Locations 
1 and 2, it is unlikely that there is any real difference 
in survival between the two locations.
Although the numbers in Table 8 suggest that it 
would be reasonable to pool over Locations 1 and 2 for 
comparison with Location 3 for Durations L and M, it was 
decided to compare Location 3 with Location 1 only as 
this gives independence of X-ray treatments.
From the results in Table 15, no difference in 
survival between Locations 1 and 3 is apparent for 
Durations M and L. It is obviously impossible (Table 8) 
to make any such comparison for Duration H, and 
investigation of the other locations is also impossible 
because of the small numbers.
Table 15. SND and relative incidence rate for location 
contrast.
Duration Location Number of SND 0. / _
deaths Ex-IMcfll
L,M 1
3
22
18 17.5316 9.3072 0.01
0. 98 
1.03
4,4 Conclusion
Although the various factors are very confused with 
one another, it seems unlikely that any have an effect on 
survival apart from duration of symptoms and X-rays. The 
effect of duration is the most marked; in general, patients
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with a higher duration of symptoms survive for longer, 
although there is probably some interaction with X-rays. 
It is possible that X-rays have a long-term effect only 
on patients with high duration of symptoms.
The data might usefully be investigated more fully 
using Cox’s regression model; this would enable account 
to be taken of individual lengths of duration of symptoms, 
instead of the rather arbitrary grouping used.
Covariates should be included for X-rays, duration of 
symptoms, and X-raysxdurâtion interaction.
4,5 Discussion
Although no analysis of a small amount of data can 
be entirely satisfactory, a regression model does provide 
a way of making the most of the available information. 
However, where the number of possible covariates is large, 
regression methods can become clumsy and tedious to apply. 
Some preliminary analysis of the data in strata, as 
demonstrated in this section, becomes essential in order 
to decide which covariates should be included. Such an 
analysis also has the advantage of promoting a greater 
awareness of the ways in which the various factors are 
related. It is more readily understood by the layman 
than a full regression analysis, and any fuller investi­
gation using a regression model may then be presented as 
a refinement of the preliminary analysis.
Two further points should be made in connection with 
the regression model. The first is that in general, 
where regression methods are used, some check on the
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validity of the model may be made by examining residuals. 
No such check is available with Cox’s model, since the 
form of the underlying distribution is unspecified. The 
second point concerns interactions. With the grouping 
used on the current set of data, 3 levels for X-rays and 
3 for duration provide 2x2 = 4 degrees of freedom for 
interaction between these two factors. This is too many 
for an intelligible analysis, and by pooling the sub­
groups in Table 10 we have reduced the number of degrees 
of freedom to 1. However, if numbers permitted, we might 
usefully pool to form a 2x3 table and retain 2 degrees of 
freedom in order to describe the interaction more fully. 
In the simplest form of regression model including an 
interaction term, in which may be written 
p,%, 4- > only one degree of freedom is
available for interaction; it is assumed that the effect 
of X-rays on survival varies linearly over durations.
If, as our graphical investigation suggests, this is not 
the case, X-r&ys having no effect except where duration 
of symptoms is high, it is possible that the regression 
analysis may show no significant interaction even if one 
exists. Since interactions can be of considerable 
importance in medical studies, the preliminary inspection 
for interactions might be followed, where numbers permit, 
by a separate regression analysis for each differently- 
reacting subgroup, in order to describe the treatment 
effects as clearly as possible.
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4.6 Summary
The analysis is considered of a set of data 
consisting of the times of death or censoring of 93 
patients in a clinical trial, together with information 
on each patient about seven other factors which might 
influence survival. Relationships between the factors 
are investigated, and the data are broken down into 
subgroups and analysed by the methods of 2^. Although 
numbers are small so that the breakdown cannot be 
complete enough for a satisfactory analysis, this is 
nevertheless a useful preliminary; a subsequent analysis 
using Gox’s regression model is suggested, in which only 
two of the factors and their interaction need be 
considered.
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